Opdualag — Total Revenues
Bristol-Myers Squibb Opdualag — Total Revenues decreased by 15.7% to $295M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.1%, from $252M to $295M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong market adoption and successful clinical positioning of the drug, while a decrease may signal increased competition or loss of market share in the immuno-oncology space.
Detailed definition
This metric represents the total global net sales generated from the commercialization of Opdualag, a fixed-dose combina...
Peer comparison
Comparable to revenue metrics for specific high-growth specialty pharmaceutical products or blockbusters in the oncology portfolios of peer biopharmaceutical companies.
bmy_segment_opdualag_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $6M | $58M | $84M | $104M | $117M | $154M | $166M | $190M | $206M | $235M | $233M | $254M | $252M | $284M | $299M | $350M | $295M |
| QoQ Change | — | — | — | — | +866.7% | +44.8% | +23.8% | +12.5% | +31.6% | +7.8% | +14.5% | +8.4% | +14.1% | -0.9% | +9.0% | -0.8% | +12.7% | +5.3% | +17.1% | -15.7% |
| YoY Change | — | — | — | — | — | — | — | >999% | +165.5% | +97.6% | +82.7% | +76.1% | +52.6% | +40.4% | +33.7% | +22.3% | +20.9% | +28.3% | +37.8% | +17.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's opdualag — total revenues?
- Bristol-Myers Squibb (BMY) reported opdualag — total revenues of $295M in Q1 2026.
- How has Bristol-Myers Squibb's opdualag — total revenues changed year-over-year?
- Bristol-Myers Squibb's opdualag — total revenues increased by 17.1% year-over-year, from $252M to $295M.
- What does opdualag — total revenues mean?
- The total revenue generated from sales of the oncology drug Opdualag.